Pacira BioSciences Inc
NASDAQ:PCRX
Other Pre-Announcement
Pacira Biosciences Says Not Providing 2022 Revenue Or Gross Margin Guidance At This Time
Published: 06/14/2022 12:34 GMT
Pacira BioSciences Inc (PCRX) - Pacira Biosciences Reports Preliminary Net Product Sales for Exparel and Iovera° of $46.0 Million for May 2022.
Pacira Biosciences Inc Says Company Not Providing 2022 Revenue Or Gross Margin Guidance at This Time Given Continued Uncertainty Around Covid-19.
Pacira Biosciences Inc Says Company Not Providing 2022 Revenue Or Gross Margin Guidance at This Time Given Continued Uncertainty Around Covid-19.